GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinsin Pharmaceutical Co Ltd (XKRX:002800) » Definitions » EPS (Basic)

Sinsin Pharmaceutical Co (XKRX:002800) EPS (Basic) : ₩363.00 (TTM As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Sinsin Pharmaceutical Co EPS (Basic)?

Sinsin Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ₩66.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩363.00.

Sinsin Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2025 was ₩66.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩363.00.

Sinsin Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2025 was ₩66.14. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 397.64.

During the past 12 months, Sinsin Pharmaceutical Co's average EPS without NRIGrowth Rate was 30.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Sinsin Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 45.30% per year. The lowest was -25.30% per year. And the median was 3.15% per year.


Sinsin Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Sinsin Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinsin Pharmaceutical Co EPS (Basic) Chart

Sinsin Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.00 -97.00 291.00 308.00 322.00

Sinsin Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.00 180.00 71.00 46.00 66.00

Sinsin Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sinsin Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(4888.498-0)/15.182
=321.99

Sinsin Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1004.955-0)/15.227
=66.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩363.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinsin Pharmaceutical Co  (XKRX:002800) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sinsin Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sinsin Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinsin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
776-6, Wonsi-Dong, Danwon-Ku, Kyunggi-Do, Ansan City, KOR
Sinsin Pharmaceutical Co Ltd is a pharmaceutical company, which manufactures and sells pharmaceutical products in South Korea. It offers pain relief and treatment products, including pain relief patches, creams, and sprays; insects care products, such as mosquito repellents and anti-perspirants; foot care products; head lice and dandruff care products; protection bands; and other products.

Sinsin Pharmaceutical Co Headlines

No Headlines